Governance Tempus AI, Inc.

TEM

US88023B1035

Biotechnology & Medical Research

Market Closed - Nasdaq Other stock markets 04:00:00 2026-05-18 pm EDT			5-day change	1st Jan Change
43.62 ^USD	-0.71%		-9.99%	-26.13%

May. 08	Exchange-Traded Funds, Equity Futures Higher Pre-Bell Friday Amid Employment Data	MT
May. 08	Tempus AI Prices Upsized $400 Million Senior Notes Offering	MT

Executive Committee: Tempus AI, Inc.

Manager

Positions heldSince

Eric Lefkofsky

56 year

Chief Executive Officer	2015-07-31
Founder	2015-07-31

Erik Phelps

55 year

Chief Administrative Officer	2020-05-31
General Counsel	2020-05-31

Greg Fisbeck

Chief Tech/Sci/R&D Officer

2021-02-28

Ezra Cohen

Chief Tech/Sci/R&D Officer

2023-05-08

Patty Spiller

Sales & Marketing

2021-04-30

Shane Colley

Chief Tech/Sci/R&D Officer

2016-12-31

Andrew Polovin

52 year

General Counsel	2020-05-31
Corporate Secretary	2024-03-31

Elizabeth Krutoholow

Investor Relations Contact

2023-04-30

A. Sasser

49 year

Chief Tech/Sci/R&D Officer

2022-10-24

Ryan Bartolucci

44 year

Comptroller/Controller/Auditor

2021-04-30

Ryan Fukushima

40 year

Chief Operating Officer

2015-08-31

Stacey Y. Kraft

Human Resources Officer

2022-04-30

Patrick Rogers

40 year

Director of Finance/CFO

2017-07-31

Composition of the Board of Directors: Tempus AI, Inc.

Director

CommitteesSince

Eric Lefkofsky

56 year

Executive Committee

Wayne Frederick

54 year

Compensation Committee Chair	2020-02-19
Organization Committee Chair	2020-02-19
Compensation Committee	2020-10-19
HR Committee	2020-10-19
Governance Committee	2022-06-21
Nominating Committee	2022-06-21
Audit Committee
Governance Committee Chair

Theodore Leonsis

70 year

Compensation Committee	2010-07-18
Governance Committee	2010-07-18
Nominating Committee	2010-07-18
Audit Committee
Executive Committee	2018-12-31
Governance Committee Chair	2018-12-31
Nominating Committee Chair	2018-12-31

Peter Barris

74 year

Finance Committee
Audit Committee	2017-08-31
Governance Committee	2011-01-31
Nominating Committee	2011-01-31
Executive Committee	2017-08-31
Compensation Committee Chair	2017-08-31

Nadja West

64 year

Audit Committee	2019-09-04
Executive Committee	2019-09-04
Compensation Committee	2021-03-31
Governance Committee	2019-10-06
Nominating Committee	2019-10-06

David Epstein

64 year

Compensation Committee	2024-02-19
Governance Committee	2024-02-19
Nominating Committee	2024-02-19

Scott Gottlieb

54 year

Governance Committee	2025-03-27
Nominating Committee	2025-03-27
Executive Committee

Jennifer Doudna

62 year

Governance Committee	2021-03-31
Nominating Committee	2021-03-31

Eric Belcher

57 year

Audit Committee Chair

2018-12-31

Latest Appointments: Tempus AI, Inc.

Nov. 18	UnitedHealth Group Appoints Scott Gottlieb to Its Board of Directors as an Independent Director, Effective November 18, 2025	CI
25-04-18	Tempus AI, Inc. Unveils Advisory Board Featuring Leading Physicians from Across the U.S	CI

More news

Former Officers and Directors: Tempus AI, Inc.

Insider

Positions held

SinceUntil

Marc Yoskowitz

Corporate Officer/Principal

2019-01-31

2023-12-31

Joel Dudley

Consultant / Advisor	2022-07-31	2023-07-31
Chief Tech/Sci/R&D Officer	2020-07-31	2022-07-31
Corporate Officer/Principal	2019-09-30	2020-08-31

Kimberly Blackwell

Chief Tech/Sci/R&D Officer

2020-02-29

2022-05-15

Kevin P. White

Chief Tech/Sci/R&D Officer	-	2020-08-31
President	-	-

Trisha Degg

Corporate Officer/Principal

2019-10-31

2020-05-31

Robert Ghenchev

Director/Board Member

2019-04-30

Brad Keywell

Corporate Officer/Principal

2015-07-31

Age distribution of managers

Parity Men Women

Male	22
Female	8

Of which Executive Committee

Male	10
Female	3

Of which Directors

Male	9
Female	0

Revisions

Recommandations analystes

Évolution recommandations analystes 1 an

Évolution recommandations analystes 4 mois

Objectif analystes

Évolution objectif analystes 1 an

Évolution objectif analystes 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Controverses sur les droits de l'Homme

Controverses Subventions fiscales

Conforme à la finance Islamique

Tempus AI, Inc. is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. It offers AI-enabled precision medicine solutions to physicians to deliver personalized patient care and, in parallel, facilitates discovery, development and delivery of optimal therapeutics. It provides three product lines: Genomics, Data and artificial intelligence applications (AI). The Genomics product line leverages its laboratories to provide next generation sequencing (NGS) diagnostics, polymerase chain reaction, profiling, molecular genotyping and other anatomic and molecular pathology testing. The data generated in its lab or ingested into its platform is structured and de-identified, prior to commercialization. Its AI Applications is focused on developing and providing diagnostics that are algorithmic in nature, implementing new software as a medical device, and building and deploying clinical decision support tools.

Employees

3,800

Sector

Biotechnology & Medical Research

More about the company